Heron Therapeutics to Report Fourth Quarter and Full Year 20

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing...

Related Keywords

David Szekeres , Exchange Commission , Prnewswire Heron Therapeutics Inc , Heron Therapeutics Inc , Nasdaq , Investor Relations , Heron Therapeutics , Private Securities Litigation Reform Act , Media Contact , Vice President , Chief Operating , Nc , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Conference Call Announcements ,